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Abstract 
Objective: To illustrate how to evaluate the need of complex strategies for developing generalizable prediction models in large 
clustered datasets. 
Study Design and Setting: We developed eight Cox regression models to estimate the risk of heart failure using a large population- 
level dataset. These models differed in the number of predictors, the functional form of the predictor effects (non-linear effects and 
interaction) and the estimation method (maximum likelihood and penalization). Internal-external cross-validation was used to evaluate 
the models’ generalizability across the included general practices. 
Results: Among 871,687 individuals from 225 general practices, 43,987 (5.5%) developed heart failure during a median follow-up 
time of 5.8 years. For discrimination, the simplest prediction model yielded a good concordance statistic, which was not much improved 
by adopting complex strategies. Between-practice heterogeneity in discrimination was similar in all models. For calibration, the simplest 
model performed satisfactorily. Although accounting for non-linear effects and interaction slightly improved the calibration slope, it also 
led to more heterogeneity in the observed/expected ratio. Similar results were found in a second case study involving patients with 
stroke. 
Conclusion: In large clustered datasets, prediction model studies may adopt internal-external cross-validation to evaluate the gen- 
eralizability of competing models, and to identify promising modelling strategies. © 2021 The Authors. Published by Elsevier Inc. 
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What is new? 
Key findings 
Flexible modelling strategies did not improve pre- 
diction model performance across different settings 
and populations. 
Although the inclusion of additional predictors 
marginally improved the model’s discriminative per- 
formance, it also increased between-practice hetero- 
geneity (thereby impairing model generalizability). 
What this adds to what was known 
In contrast to traditional internal validation meth- 
ods, internal-external cross-validation (IECV) can 
quantify the generalizability of a prediction model 
across different settings and populations. 
What is the implication and what should change 
now? 
When developing prediction models using large 
clustered datasets, both their internal and external va- 
lidity should be studied. 
IECV can be used to compare the practical bene- 
fits of different modelling strategies, and to simplify 
model complexity. 
1. Introduction 
In medicine, there are an increasing number of clini-
cal prediction models [1] . These models aim to predict a
risk of having a certain condition or experiencing a health
event in the future. Prediction models are often developed
using a single and small dataset. This leads to prediction
models that are more prone to overfitting with the dataset
used for its development, which leads to poor accuracy and
less generalizability of risk predictions when the model is
validated or used in new individuals. 
For this reason, there has been a growing interest in
prediction model studies using large datasets from elec-
tronic health records (EHRs), multi-center studies or indi-
vidual participant data [2–5] . An advantage of such large
datasets is that parameters of the prediction model can
accurately be estimated, thereby facilitating the develop-
ment of complex models with many predictors, interaction
terms and/or non-linear effects. Furthermore, a common
feature of these large datasets is that individuals are often
clustered within hospitals, primary care practices, or even
within countries. Clusters may differ with respect to in-
cluded participants, variable definitions and measurement
methods, all of which may affect the generalizability of
developed prediction models. The presence of clustering,
however, also offers an important opportunity, as the per-
formance of a prediction model can be examined on mul-tiple occasions and thus be used to explore its generaliz-
ability across different settings and populations. Recently,
various strategies for such analyses using large clustered
data have been proposed [2 , 5–8] . 
The aim of this study was to illustrate how advanced
methods can be used to evaluate the need of complex
strategies for developing generalizable clinical prediction
models in large clustered datasets. 
2. Methods 
For illustration purpose, we used two case studies. 
2.1. Case study 1 
We compared various modelling strategies using an ex-
ample of a prediction model for the incidence of heart
failure (HF). In the field of cardiovascular diseases (CVD),
HF is one of the most relevant outcomes due to its high
morbidity and mortality [9–12] . 
2.1.1. Source of the data 
We used an existing large population-level dataset
which links three sources of EHRs in England: pri-
mary care records from the clinical practice research
datalink (CPRD), secondary care diagnoses and proce-
dures recorded during admissions in hospital episodes
statistics (HES), and the cause-specific death registra-
tion information sourced from the office for national
statistics (ONS) registry. This study was carried out as
part of the CALIBER resource ( https://www.ucl.ac.uk/
healthinformatics/ caliber and https:// www.caliberresearch.
org/) [13 , 14] . CALIBER, led from the UCL Institute of
Health Informatics, is a research resource providing vali-
dated EHR phenotyping algorithms and tools for national
structured data sources. Data were recorded in five con-
trolled clinical terminologies: Read version 2 (CPRD diag-
noses), International classification of diseases (ICD)-9 and
ICD-10 (HES diagnoses, ONS causes of death), the Of-
fice of Population Censuses and Surveys (OPCS)-4 (HES
procedures) and British National Formulary (BNF) (CPRD
medication prescriptions). The study was approved by the
MHRA (UK) Independent Scientific Advisory Committee
(14_246RMnA2), under Section 251 (NHS Social Care Act
2006). 
2.1.2. Population 
The construction of this cohort has been described by
Uijl et al [15] . Briefly, we selected all individuals that were
55 years or older between January 1, 2000 and March 25,
2010, and had at least 1 year of follow-up by a general
practitioner, in a practice that had at least 1 year of up-
to-standard data recording in CPRD. The last date of the
follow-up between the period above was considered co-
hort entry date (index date). Individuals with a history of
































































































HF before their index date were excluded. The study flow
diagram is shown in Appendix A. 
2.1.3. Predictors 
We identified predictors that are commonly measured
in CPRD or HES, and commonly used for prediction
of HF [15 , 16] : age, sex, current smoking, ethnicity (CE,
Caucasian ethnicity), index of multiple deprivation (IMD),
body mass index (BMI), creatinine level (CL), and total
cholesterol (TC). IMD is a measure of multiple depriva-
tion at the small area level, consisting of seven domains
[17] . Within this set, we selected those predictors which
were least affected by missing data. The closest measure-
ment to index date between 3 years before and 1 year after
the index date was used. Detailed information about the
definition of each predictor is available on the CALIBER
website [18] . 
2.1.4. Outcomes 
The primary outcome was incidence of HF, based on
the first record of HF from CPRD or HES after the in-
dex date. In CPRD, HF was defined by a diagnosis of HF
or chronic left ventricular dysfunction on echocardiogram
with READ codes. In HES, it was defined by a diagno-
sis of HF during a hospitalization using all positions of
ICD-10. If no diagnosis of HF was made, censoring was
defined as the first event among the following: death, de-
registration from a practice, last practice data collection,
or at the study end date. 
2.1.5. Statistical analysis 
2.1.5.1. Multilevel imputation. Multiple multilevel impu-
tation, which accounts for potential heterogeneity be-
tween the included clusters, is recommended in the recent
methodological guidelines [19,34] . However, due to limited
hardware processing capacity, we applied single multilevel
imputation. Details of the imputation process are described
in Appendix B. 
2.1.5.2. Derivation and validation of prediction models.
We considered eight modelling strategies to predict the
risk of developing HF using Cox regression. These mod-
els differed with respect to the number of predictors, the
functional form of the predictor effects and the method of
estimation. Each model and their estimation method are
summarized in Table 1 . 
Models 1, 3, 5 and 7 included all predictor variables as
linear effects. Models 2, 4, 6 and 8 used RCS with three
knots for all continuous predictor variables, and interaction
terms between all possible combinations of two variables.
Model 3, 4, 7, and 8 were estimated using a ridge penalty.
For all models, the total number of regression coefficients
is displayed. 
Model 1 included four predictors (age, sex, current
smoking, and CE) as linear effects. Model 2 was an ex-
tension of Model 1 that included non-linear effect for ageand for all possible two-way interactions between the four
predictors. Model 3 and 4 included the same predictors
as Model 1 and 2, respectively, but were estimated using
a ridge penalty. Model 5 was an extension of Model 1
that also included IMD, BMI, CL and TC as linear ef-
fects. Model 6 – 8 were extended from Model 5 as similar
to Model 2 – 4 from Model 1. In models with a ridge
penalty (Model 3, 4, 7 and 8), all regression coefficients
were shrunk towards zero by penalizing the partial log-
likelihood for the magnitude of the squared coefficients
(L2-norm) [20] . This strategy has been recommended to
avoid overfitting, and to improve prediction model perfor-
mance, particularly when it is applied in new population.
We used the degree of penalty (lambda) which minimized
the mean square error in ten-fold cross validation. The pro-
portional hazards assumption of all models was checked
using the Schoenfeld residuals. 
We performed internal-external cross-validation (IECV)
to compare the performance of the aforementioned eight
prediction models at multiple occasions [2 , 6] . In contrast
to traditional internal validation methods (e.g., bootstrap-
ping, cross-validation) which evaluate the model’s perfor-
mance in new individuals from the same population (i.e.,
reproducibility), IECV assesses model performance in new
individuals from different but related practices as compared
to the original development sample. These practices (i.e.,
taken as cluster) may differ with respect to case-mix, vari-
able definitions and measurement methods, and thus al-
low to investigate the model’s generalizability [21] . Using
IECV, the data from all but one practice are used for esti-
mating the prediction model, after which its performance
is evaluated in the remaining practice. The procedure is
repeated by rotating the omitted practice, resulting in mul-
tiple estimates of prediction model performance. For each
prediction model, we assessed the model’s discrimination
performance using Harrell’s concordance (c-) statistic. For
calibration, we constructed calibration plots in the overall
population. We also estimated the calibration slope and the
ratio of observed versus expected events (O:E ratio) at 5
years of follow-up [22] . Interpretation of each performance
measure is described in Appendix C. 
The performance measures resulting from IECV were
pooled using random-effect meta-analysis [2 , 23 , 24] . This
approach not only accounts for the precision of practice-
specific performance estimates, but also quantifies the
between-practice variability (heterogeneity) of model per-
formance. Heterogeneity is quantified by the between-
practice standard deviation of model performance ( τ ) [7] .
Meta-analysis results were reported as point estimates with
95% confidence intervals (CI) and 95% prediction inter-
vals (PI). The CI indicates the precision of the model’s
average performance across all practices. Conversely, the
PI accounts for heterogeneity between practices and there-
fore indicates what performance can be expected when the
model is applied within a specific practice. 
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Table 1. Description of the eight prediction models 
Model Included predictor variables 2-way IT # RC Estimation method 
Age Male Sex Smoking CE IMD BMI CL TC 
1 L L L L - - - - No 4 Cox regression 
2 RCS L L L - - - - Yes 14 Cox regression 
3 L L L L - - - - No 4 Ridge penalized Cox 
4 RCS L L L - - - - Yes 14 Ridge penalized Cox 
5 L L L L L L L L No 8 Cox regression 
6 RCS L L L RCS RCS RCS RCS Yes 66 Cox regression 
7 L L L L L L L L No 8 Ridge penalized Cox 
8 RCS L L L RCS RCS RCS RCS Yes 66 Ridge penalized Cox 
Abbreviations: IT, interaction terms; #RC, the total number of regression coefficients; CE, Caucasian ethnicity; IMD, index of multiple deprivation; 
BMI, body mass index; CL, creatinine level; TC, total cholesterol; L, Linear effects; RCS, restricted cubic splines. 
Table 2. Baseline characteristics of the cohort 
Predictor variable Individuals with incident HF Individuals without HF Proportion of missing 
Total number of patients 43,987 823,700 
Age, years, median (IQR) 75.5 (68.5 – 81.5) 60.6 (55.0 − 70.5) 0.0% 
Male sex, n (%) 22,618 (51.4) 442,409 (53.7) 0.0% 
Caucasian ethnicity, n (%) 42,065 (95.6) 754,756 (91.6) 39.2% 
Current Smoking, n (%) 10,843 (24.7) 190,851 (23.2) 66.2% 
IMD, median (IQR) 16.2 (9.4 − 27.1) 13.7 (8.3 − 23.4) 0.3% 
BMI, kg/m2, median (IQR) 27.4 (23.9 − 31.0) 26.9 (23.6 − 30.4) 60.2% 
Creatinine, μmol/L, median (IQR) 102.4 (85.0 − 122.4) 88.7 (73.1 − 105.6) 66.5% 
Total cholesterol, mmol/L, median (IQR) 5.3 (4.6 − 6.1) 5.5 (4.8 − 6.3) 72.3% 





































2.2. Case study 2 
In this case study, we used patient-level data from
a large international, multi-center, randomized controlled
trial [25] . Because the missingness proportion was very
low (6.0%), we performed a complete case analysis. Eight
modelling strategies using ridge penalized Cox regression
model were considered to predict the risk of mortality from
CVD in patients with acute ischemic stroke. These mod-
els differed with respect to the number of predictors, the
functional form of the predictor effects (non-linear effects
and/or interaction terms). We illustrated the advantage of
IECV by comparing it with bootstrap internal validation.
More detailed information is available in Appendix D. 
All analyses were performed using R version 3.6.1. 
3. Results 
3.1. Case study 1 
The cohort included 871,687 individuals from 225 gen-
eral practices. Among these, 43,987 (5.5%) developed HF
during a median follow-up time of 5.8 years (interquartile
range [IQR] 2.7 – 9.9), with a median time-to-event of 3.7
years (IQR 1.8 – 6.4). Baseline characteristics are shown
in Table 2 . The number of patients with HF in each general prac-
tice was a median of 197 (IQR 128 – 282, range 3 – 622).
We explored heterogeneity of case-mix across the included
general practices by comparing their distribution of pre-
dicted risk according to Model 5. Results in Appendix E
indicate that the standard deviation (SD) of the linear pre-
dictor (LP) in each general practice ranged between 1.09
and 1.41, and that the mean LP in each general practice
ranged between -0.51 and 0.61. 
The estimated regression coefficients of the eight pre-
diction models, as obtained from the entire dataset, are
presented in Appendix F. These results indicate that all
included predictors were significantly associated with HF,
and that interactions were present between various predic-
tors. The performance of the estimated models, as evalu-
ated using IECV, is summarized in Table 3 . 
For all models, summary estimates were obtained us-
ing random effects meta-analysis. The SE and between-
study heterogeneity ( τ ) are given on the scale of the meta-
analysis (that is, the logit of c-statistic, the log of the O:E
ratio and identity for the calibration slope). 
3.1.1. Discrimination performance 
The c-statistic across the general practices is shown in
Appendix G. All models showed similar discrimination, al-
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Table 3. Meta-analysis results of the model performance 
Model # RC Model Estimation Summary Estimate 95% CI 95% PI SE ∗ τ∗
Discrimination performance (c-statistic) 
1 4 Cox regression 0.792 0.788 0.796 0.741 0.835 0.012 0.145 
2 14 Cox regression 0.793 0.789 0.797 0.742 0.836 0.012 0.144 
3 4 Ridge penalized Cox 0.793 0.789 0.796 0.742 0.835 0.012 0.144 
4 14 Ridge penalized Cox 0.793 0.789 0.796 0.742 0.836 0.012 0.144 
5 8 Cox regression 0.808 0.804 0.812 0.756 0.852 0.012 0.156 
6 66 Cox regression 0.806 0.802 0.810 0.744 0.856 0.014 0.180 
7 8 Ridge penalized Cox 0.808 0.804 0.812 0.757 0.851 0.012 0.153 
8 66 Ridge penalized Cox 0.809 0.805 0.813 0.754 0.854 0.013 0.163 
Calibration performance (O:E ratio at 5 years) 
1 4 Cox regression 0.957 0.926 0.990 0.598 1.532 0.017 0.239 
2 14 Cox regression 0.963 0.926 1.001 0.557 1.665 0.020 0.279 
3 4 Ridge penalized Cox 0.959 0.928 0.991 0.609 1.511 0.017 0.231 
4 14 Ridge penalized Cox 0.958 0.927 0.990 0.609 1.508 0.017 0.231 
5 8 Cox regression 0.950 0.922 0.977 0.640 1.408 0.015 0.200 
6 66 Cox regression 0.935 0.903 0.969 0.572 1.530 0.018 0.251 
7 8 Ridge penalized Cox 0.947 0.921 0.974 0.648 1.385 0.014 0.193 
8 66 Ridge penalized Cox 0.954 0.928 0.981 0.655 1.389 0.014 0.191 
Calibration performance (calibration slope) 
1 4 Cox regression 1.021 1.005 1.036 0.835 1.206 0.008 0.094 
2 14 Cox regression 1.010 0.992 1.028 0.789 1.231 0.009 0.112 
3 4 Ridge penalized Cox 1.126 1.108 1.143 0.923 1.328 0.009 0.103 
4 14 Ridge penalized Cox 1.088 1.071 1.105 0.888 1.287 0.009 0.101 
5 8 Cox regression 1.023 1.007 1.039 0.833 1.214 0.008 0.097 
6 66 Cox regression 0.992 0.975 1.008 0.792 1.191 0.008 0.101 
7 8 Ridge penalized Cox 1.138 1.120 1.156 0.917 1.358 0.009 0.112 
8 66 Ridge penalized Cox 1.077 1.061 1.092 0.892 1.261 0.008 0.094 

































though models that included more predictors yielded some-
what larger values for the c-statistic (0.79 in Model 1 – 4
vs. 0.81 in Model 5 – 8). For all models, there was no-
table between-practice heterogeneity in discrimination per-
formance. For instance, the 95% PI for a Cox regression
model including eight predictors as main effects (model 5)
ranged from 0.756 to 0.852. Estimates for the between-
study standard deviation ( τ ) were similar for all models,
but slightly larger for prediction models that included eight
predictors and allowed for non-linear effects and interac-
tions. 
3.1.2. Calibration performance 
Calibration plot. Calibration plots in Fig. 1 indicate that
predicted and observed risks were almost in perfect agree-
ment for the unpenalized Cox regression model that in-
cluded non-linear effects and interactions between predic-
tors (Model 2 and 6). 
Predicted and observed risks are almost in perfect agree-
ment for the unpenalized Cox regression models that in-cluded non-linear effects and interactions between predic-
tors (Model 2 and 6). Some under-prediction for risk esti-
mates around 10% is observed in the remaining models. 
O:E ratio. The O:E ratio across the included general prac-
tices is shown in Appendix H. All models yielded summary
O:E ratios at 5 years below one, especially those models
that included eight predictors (Model 5 – 8). In addition,
PIs indicate that all prediction models may substantially
over- or under-predict the risk of HF when applied to in-
dividual patients from a new practice. 
Calibration slope. Calibration slope across the included
general practices is shown in Appendix I. Unpenalized
prediction models yielded pooled calibration slopes most
close to one (Model 1, 2, 5, and 6). Prediction models
that adopted a ridge penalty yielded calibration slopes that
were slightly larger than one, indicating that predicted risks
did not vary enough and thus that too much shrinkage may
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Fig. 1. Calibration plots of the eight prediction models. For interpretation of the references to color in this figure legend, the reader is referred to 



































































have been applied in the development sample. For all mod-
els, the calibration slope was prone to a limited amount of
between-practice heterogeneity. For instance, the predic-
tion model that included eight predictors as main effects
(model 5) yielded a 95% PI from 0.833 to 1.214. Esti-
mates of between-study variance of the calibration slope
were similar for all models. 
Case study 2 
The detailed results are shown in Appendix D. In short,
among 16,280 patients from 14 countries, 2,745 (16.9%)
died due to any CVD related conditions. Using bootstrap
validation, we found that the c-statistic ranged from 0.65
to 0.70 with good reproducibility, and that models with
more predictors discriminated better. However, results of
IECV indicate that the inclusion of additional predictors
increased the heterogeneity in discrimination performance.
Results of both bootstrap validation and IECV also indicate
that inclusion of non-linear terms and/or interaction effects)
did not improve discrimination performance. In calibration
performance, the effect of complex modelling strategies
was small in both summary estimates of O:E ratio and
calibration slope and their generalizability. 
4. Discussion 
We illustrated how evidence synthesis methods can be
used to evaluate the need of complex strategies for de-
veloping generalizable clinical prediction models in large
clustered datasets. To this end, we applied IECV and quan-
tified the model’s average performance as well as its vari-
ability between clusters. In contrast to traditional internal
validation methods, a major advantage of using IECV in
large clustered data is that the external validity of predic-
tion models can be assessed on multiple occasions, thereby
allowing researchers to explore the generalizability of dif-
ferent modelling strategies directly during the development
process. In the case study 1, we found that adopting complex
modelling strategies did not much improve the external va-
lidity of developed prediction models for HF. In particular,
prediction models that were based on four commonly avail-
able variables yielded a c-statistic of 0.79, which is com-
parable to existing models for HF using even more than 10
predictors including laboratory tests [10 , 11] . Although the
inclusion of additional predictors marginally improved the
discriminative performance, it also slightly increased the
between-practice heterogeneity. When investigating model
calibration, we found that all prediction modelling strate-
gies yielded adequate calibration performance on average.
However, because of between-practice heterogeneity, local
revisions were often deemed necessary. In the case study
2, we also found that complex modelling did not meaning-
fully improve the generalizability of the prediction models,
although the inclusion of additional predictors moderately
improved their discrimination performance. 
As we found in the case study 1, the incremental value
of candidate predictors is often small in prediction model
studies for the incidence of CVD [26 , 27] . For instance,
systematic reviews have demonstrated a lack of incremen-
tal value for cholesterol level [27] , BMI [27] , and even
biomarkers (e.g., triglycerides, C-reactive protein) for pre-
dicting CVD [26] . For this reason, it may sometimes be
more advantageous to consider the inclusion of non-linear
effects or interaction terms, rather than adding more pre-
dictors. This strategy is common in machine learning,
where methods no longer assume additive linear effects and
adopt penalization to avoid overfitting. We mimicked the
use of flexible modelling strategies by including non-linear
effects and non-linear interaction terms. However, this
strategy also failed to improve model discrimination. Sim-
ilar findings also have been reported in prediction model
studies for the prognosis of patients with CVD [28 , 29] .
For instance, a recent study adopting advanced machine
learning algorithms failed to outperform traditional pre-






























































































diction models for readmissions in patients with HF, and
yielded c-statistics around 0.60 [28] . In another study, dis-
crimination performance to predict all-cause mortality in
patients with coronary artery disease marginally increased
from 0.793 (Cox regression model with 27 predictors) to
0.797 (random survival forests with 98 predictors) and to
0.801 (elastic net Cox regression model with 586 predic-
tors) [29] . More generally, there is limited evidence that
machine learning models can outperform simple prediction
models involving additive linear terms, especially when
predictions are only based on structured epidemiological
data [30] . 
The following limitations need to be considered. In the
first case study, the substantial presence of missing data
was an important concern. Although we focused on the
inclusion of variables with relatively few missing values,
some were missing for more than 70% of participants.
Multiple imputation is generally recommended to obtain
reliable standard errors of the performance measures but
only single imputation was pursued due to limited hard-
ware processing capacity. There is still limited guidance
on how to implement multiple imputation when develop-
ing and validating a prediction model in large clustered
datasets. Key issues that remain unclear are (i) how to com-
bine multiple imputation with sampling procedures (e.g.,
IECV) [31 , 32] , (ii) the order of pooling estimates (across
imputations or across clusters first) [33] . Another limi-
tation was that we were not able to include non-linear
and interaction terms in the imputation model due to non-
convergence issues. Therefore, continuous variables were
imputed as a linear term and no interaction term was in-
cluded in imputation models. This strategy may have fa-
vored simpler modelling strategies in IECV. For this rea-
son, we implemented those modelling strategies in the case
study 2 where the presence of missing data was much less
a concern. Here, we found similar findings to those in the
case study 1. 
Second, eligible individuals in both case studies were
enrolled more than ten years ago. It is possible that popu-
lation characteristics have substantially changed over time,
and that complex associations (e.g., non-linear predictor
effects or interaction terms) have become more common. 
Third, we focused on regression-based methods and did
not evaluate other flexible modelling strategies such as neu-
ral networks or random forests. It is possible that these
strategies could yield more promising results, especially if
(interaction between) predictor effects cannot adequately
be described using the regression-based methods consid-
ered here. 
5. Conclusion 
We recommend the use of IECV in large clustered
datasets to assess the generalizability of prediction models
during their development, and to identify whether complex
modelling strategies may offer any advantages. In contrastto traditional internal validation methods, IECV allows to
evaluate model performance in non-random hold-out sam-
ples with individuals from different settings or populations.
In our case studies, we found that accurate prediction does
not necessarily require complex modelling strategies, and
that the need for local updating may be inevitable regard-
less of how much data are at hand during the model’s
development. 
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from https:// datashare.ed.ac.uk/ handle/ 10283/ 124. 
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